Tag:
CorMedix
Latest Headlines
Latest Headlines
CorMedix prices IPO
New Jersey-based CorMedix has raised $12.5 million through the sale of 1.9 million units at $6.50. The company, which is developing products for the treatment of cardiac and renal dysfunction, notes
